Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 404

PubMed (RefSeq) Links for Nucleotide (Select 269973860)

1.

[The STAT5 signaling in the expression of alpha-subunit of interleukin-2 receptor in human blood lymphocytes].

Mitiushova EV, Shatrova AN, Zenin VV, Aksenov ND, Marakhova II.

Tsitologiia. 2013;55(6):421-9. Russian.

PMID:
25509109
2.

Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?

Lange M, Żawrocki A, Nedoszytko B, Wasąg B, Niedoszytko M, Jassem E, Nowicki R, Żmijewski MA, Biernat W.

Int Arch Allergy Immunol. 2014;165(2):104-10. doi: 10.1159/000368799. Epub 2014 Nov 15.

PMID:
25402852
3.

CD25(+) Bcl6(low) T follicular helper cells provide help to maturing B cells in germinal centers of human tonsil.

Li H, Pauza CD.

Eur J Immunol. 2015 Jan;45(1):298-308. doi: 10.1002/eji.201444911. Epub 2014 Oct 27.

PMID:
25263533
4.

Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses.

Climent N, Munier S, Piqué N, García F, Pavot V, Primard C, Casanova V, Gatell JM, Verrier B, Gallart T.

Vaccine. 2014 Oct 29;32(47):6266-76. doi: 10.1016/j.vaccine.2014.09.010. Epub 2014 Sep 19.

PMID:
25240755
5.

CD4+CD25highFOXP3+ T regulatory cells as a biomarker of disease activity in systemic lupus erythematosus: a prospective study.

Tselios K, Sarantopoulos A, Gkougkourelas I, Boura P.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5):630-9. Epub 2014 Sep 8.

PMID:
25197969
6.

PIM inhibitors target CD25-positive AML cells through concomitant suppression of STAT5 activation and degradation of MYC oncogene.

Guo Z, Wang A, Zhang W, Levit M, Gao Q, Barberis C, Tabart M, Zhang J, Hoffmann D, Wiederschain D, Rocnik J, Sun F, Murtie J, Lengauer C, Gross S, Zhang B, Cheng H, Patel V, Schio L, Adrian F, Dorsch M, Garcia-Echeverria C, Huang SM.

Blood. 2014 Sep 11;124(11):1777-89. doi: 10.1182/blood-2014-01-551234. Epub 2014 Jul 8.

PMID:
25006129
7.

The variation of expression of CD4+ CD25+ Foxp3+ regulatory T cells in patients with Helicobacter pylori infection and eradication.

Chen T, Jin R, Huang Z, Hong W, Chen Z, Wang J.

Hepatogastroenterology. 2014 Mar-Apr;61(130):507-11.

PMID:
24901172
8.

Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression.

Traboulsee AL, Bernales CQ, Ross JP, Lee JD, Sadovnick AD, Vilariño-Güell C.

Neurogenetics. 2014 Aug;15(3):165-9. doi: 10.1007/s10048-014-0403-3. Epub 2014 Apr 26.

PMID:
24770783
9.

Human antigen-specific CD4⁺ CD25⁺ CD134⁺ CD39⁺ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses.

Seddiki N, Cook L, Hsu DC, Phetsouphanh C, Brown K, Xu Y, Kerr SJ, Cooper DA, Munier CM, Pett S, Ananworanich J, Zaunders J, Kelleher AD.

Eur J Immunol. 2014 Jun;44(6):1644-61. doi: 10.1002/eji.201344102. Epub 2014 Apr 29.

PMID:
24752698
10.

Staphylococcus aureus convert neonatal conventional CD4(+) T cells into FOXP3(+) CD25(+) CD127(low) T cells via the PD-1/PD-L1 axis.

Rabe H, Nordström I, Andersson K, Lundell AC, Rudin A.

Immunology. 2014 Mar;141(3):467-81. doi: 10.1111/imm.12209.

11.

Soluble IL-2 receptor: a biomarker for assessing myositis activity.

Tournadre A, Dubost JJ, Soubrier M, Ruivard M, Souteyrand P, Schmidt J, Clavelou P, Tridon A, Ristori JM.

Dis Markers. 2014;2014:472624. doi: 10.1155/2014/472624. Epub 2014 Feb 4.

12.

Soluble CD25 is increased in patients with sepsis-induced acute kidney injury.

Cho E, Lee JH, Lim HJ, Oh SW, Jo SK, Cho WY, Kim HK, Lee SY.

Nephrology (Carlton). 2014 Jun;19(6):318-24. doi: 10.1111/nep.12230.

PMID:
24646167
13.

Functional NK cell repertoires are maintained through IL-2Rα and Fas ligand.

Felices M, Lenvik TR, Ankarlo DE, Foley B, Curtsinger J, Luo X, Blazar BR, Anderson SK, Miller JS.

J Immunol. 2014 Apr 15;192(8):3889-97. doi: 10.4049/jimmunol.1302601. Epub 2014 Mar 14.

14.

Family studies of type 1 diabetes reveal additive and epistatic effects between MGAT1 and three other polymorphisms.

Yu Z, Li CF, Mkhikian H, Zhou RW, Newton BL, Demetriou M.

Genes Immun. 2014 Apr;15(4):218-23. doi: 10.1038/gene.2014.7. Epub 2014 Feb 27.

15.

Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.

Leger PD, Johnson DH, Robbins GK, Shafer RW, Clifford DB, Li J, McLaren PJ, Haas DW.

J Neurovirol. 2014 Jun;20(3):304-8. doi: 10.1007/s13365-014-0235-9. Epub 2014 Feb 20.

PMID:
24554482
16.

Viremic long-term nonprogressive HIV-1 infection is not associated with abnormalities in known Nef functions.

Heigele A, Camerini D, van't Wout AB, Kirchhoff F.

Retrovirology. 2014 Feb 4;11:13. doi: 10.1186/1742-4690-11-13.

17.

Diphtheria toxin-based bivalent human IL-2 fusion toxin with improved efficacy for targeting human CD25(+) cells.

Peraino JS, Zhang H, Rajasekera PV, Wei M, Madsen JC, Sachs DH, Huang CA, Wang Z.

J Immunol Methods. 2014 Mar;405:57-66. doi: 10.1016/j.jim.2014.01.008. Epub 2014 Jan 24.

18.

Novel rheumatoid arthritis susceptibility locus at 22q12 identified in an extended UK genome-wide association study.

Orozco G, Viatte S, Bowes J, Martin P, Wilson AG, Morgan AW, Steer S, Wordsworth P, Hocking LJ; UK Rheumatoid Arthritis Genetics Consortium; Wellcome Trust Case Control Consortium; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate Consortium, Barton A, Worthington J, Eyre S.

Arthritis Rheumatol. 2014 Jan;66(1):24-30. doi: 10.1002/art.38196.

19.

Genetics of rheumatoid arthritis contributes to biology and drug discovery.

Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, Kochi Y, Ohmura K, Suzuki A, Yoshida S, Graham RR, Manoharan A, Ortmann W, Bhangale T, Denny JC, Carroll RJ, Eyler AE, Greenberg JD, Kremer JM, Pappas DA, Jiang L, Yin J, Ye L, Su DF, Yang J, Xie G, Keystone E, Westra HJ, Esko T, Metspalu A, Zhou X, Gupta N, Mirel D, Stahl EA, Diogo D, Cui J, Liao K, Guo MH, Myouzen K, Kawaguchi T, Coenen MJ, van Riel PL, van de Laar MA, Guchelaar HJ, Huizinga TW, Dieudé P, Mariette X, Bridges SL Jr, Zhernakova A, Toes RE, Tak PP, Miceli-Richard C, Bang SY, Lee HS, Martin J, Gonzalez-Gay MA, Rodriguez-Rodriguez L, Rantapää-Dahlqvist S, Arlestig L, Choi HK, Kamatani Y, Galan P, Lathrop M; RACI consortium; GARNET consortium, Eyre S, Bowes J, Barton A, de Vries N, Moreland LW, Criswell LA, Karlson EW, Taniguchi A, Yamada R, Kubo M, Liu JS, Bae SC, Worthington J, Padyukov L, Klareskog L, Gregersen PK, Raychaudhuri S, Stranger BE, De Jager PL, Franke L, Visscher PM, Brown MA, Yamanaka H, Mimori T, Takahashi A, Xu H, Behrens TW, Siminovitch KA, Momohara S, Matsuda F, Yamamoto K, Plenge RM.

Nature. 2014 Feb 20;506(7488):376-81. doi: 10.1038/nature12873. Epub 2013 Dec 25.

20.

Genome-wide association analysis identifies 11 risk variants associated with the asthma with hay fever phenotype.

Ferreira MA, Matheson MC, Tang CS, Granell R, Ang W, Hui J, Kiefer AK, Duffy DL, Baltic S, Danoy P, Bui M, Price L, Sly PD, Eriksson N, Madden PA, Abramson MJ, Holt PG, Heath AC, Hunter M, Musk B, Robertson CF, Le Souëf P, Montgomery GW, Henderson AJ, Tung JY, Dharmage SC, Brown MA, James A, Thompson PJ, Pennell C, Martin NG, Evans DM, Hinds DA, Hopper JL; Australian Asthma Genetics Consortium Collaborators.

J Allergy Clin Immunol. 2014 Jun;133(6):1564-71. doi: 10.1016/j.jaci.2013.10.030. Epub 2013 Dec 31.

PMID:
24388013
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk